Tectonic Therapeutic, Inc.

NASDAQ:TECX

Biotechnology

Healthcare
$21.04 -0.96%

-$0.29 today

Market cap
$411.32M
Beta
1.22
P/E (TTM)
-6.7
EPS (TTM)
-$4.45
52W Low $14.39High $36.03

Volume 0.17M

Average 0.20M

Returns on capital

Tectonic Therapeutic, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-29.5%

avg -67.4%

ROIC

-33.3%

avg -1422.1%

ROA

-28.4%

avg -73.8%

Analysis

ROA is currently the strongest return metric at -28.4% versus its period average of -73.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Alise S. Reicin

President, Chief Executive Officer, Secretary & DirectorUSD 1.03M65——

Daniel Lochner

Chief Financial OfficerUSD 728.71K4458.02K0.31%

Marcella K. Ruddy

Chief Medical OfficerUSD 723.25K6367.16K0.36%

Mary West

Senior Vice President of Clinical Development Operations————

Marc Schwabish

Chief Business Officer—4644.90K0.24%

John Diener

Senior Vice President of Antibody Engineering & Protein Sciences————

Anthony Muslin

Chief Development Officer————

Washington Alves

Senior Vice President of Technical Operations————

Geraldine Peters-Wiles

Senior Vice President of Human Resources————

Peter McNamara

Chief Scientific Officer—5454.30K0.29%

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 30, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

3

$235,160.00

Sells

11

$651,006.74

Net Transaction Value

−$415,846.74

Net selling

Most Active

McNamara Peter

8 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 30, 26

McNamara Peter

Direct

Sell$12.3K
Aug 25, 26

McNamara Peter

Direct

Sell$1.6K
Aug 12, 26

McNamara Peter

Direct

Sell$1.5K
Jun 30, 26

McNamara Peter

Direct

Sell$6K
May 4, 26

Ruddy Marcella K.

Direct

Sell$32K
Apr 1, 26

Ruddy Marcella K.

Direct

Sell$31.1K
Mar 6, 26

McNamara Peter

Direct

Sell$181.4K
Mar 6, 26

McNamara Peter

Direct

Sell$7.5K
Mar 6, 26

Ruddy Marcella K.

Direct

Sell$300K
Mar 4, 26

McNamara Peter

Direct

Sell$41.3K

1–10 of 14

Summary

Insiders reported 3 buys worth $235,160.00 and 11 sells worth $651,006.74 over the last 12 months. That adds up to net selling of $415,846.74. McNamara Peter was the most active insider with 8 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A6 analysts
RevenueN/AN/AN/A
N/A6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Tectonic Therapeutic, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about TECX's management, answered from reported figures.

Who manages TECX?

Tectonic Therapeutic, Inc. (TECX) lists 10 active executives. The top listed executive is Alise S. Reicin, President, Chief Executive Officer, Secretary & Director.

Are TECX insiders buying or selling?

Recent insider activity shows net buying of $90.55M.